7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          A reservoir of latently infected cells poses the greatest challenge to HIV-1 eradication. Efforts to develop strategies to eliminate the reservoir have been hampered, in part, by the lack of a precise understanding of the cellular and molecular nature of this reservoir. We describe a new method to analyze the replication-competent latent reservoir quantitatively and qualitatively. We find that over 50% of the replication-competent viruses in the reservoir form part of groups with identical env sequences. However, a negative correlation exists between integrated proviral clones and replication-competent viruses, such that the larger the proviral clone, the lower is its probability of representing a replication-competent virus.

          Abstract

          HIV-1–infected individuals harbor a latent reservoir of infected CD4 + T cells that is not eradicated by antiretroviral therapy (ART). This reservoir presents the greatest barrier to an HIV-1 cure and has remained difficult to characterize, in part, because the vast majority of integrated sequences are defective and incapable of reactivation. To characterize the replication-competent reservoir, we have combined two techniques, quantitative viral outgrowth and qualitative sequence analysis of clonal outgrowth viruses. Leukapheresis samples from four fully ART-suppressed, chronically infected individuals were assayed at two time points separated by a 4- to 6-mo interval. Overall, 54% of the viruses emerging from the latent reservoir showed gp160 env sequences that were identical to at least one other virus. Moreover, 43% of the env sequences from viruses emerging from the reservoir were part of identical groups at the two time points. Groups of identical expanded sequences made up 54% of proviral DNA, and, as might be expected, the sequences of replication-competent viruses in the active reservoir showed limited overlap with integrated proviral DNA, most of which is known to represent defective viruses. Finally, there was an inverse correlation between proviral DNA clone size and the probability of reactivation, suggesting that replication-competent viruses are less likely to be found among highly expanded provirus-containing cell clones.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

          The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy. Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral messenger RNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection. Uncertainty remains over what fraction of CD4+ T cells are infected and whether there are latent reservoirs for the virus. We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated provirus (<10(7) cells). The most prevalent form of HIV-1 DNA in resting and activated CD4+ T cells is a full-length, linear, unintegrated form that is not replication competent. The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+ T cells and macrophages.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

              Although it is presumed that the integration of HIV-1 into the genome of infected CD4+ T lymphocytes allows viral persistence, there has been little direct evidence that CD4+ T cells with integrated provirus function as a latent reservoir for HIV-1 in infected individuals. Using resting CD4+ T-cell populations of extremely high purity and a novel assay that selectively and unambiguously detects integrated HIV-1, we show that resting CD4+ T cells harbouring integrated provirus are present in some infected individuals. However, these cells do not accumulate within the circulating pool of resting CD4+ T cells in the early stages of HIV-1 infection and do not accumulate even after prolonged periods in long-term survivors of HIV-1 infection. These results suggest that because of viral cytopathic effects and/or host effector mechanisms, productively infected CD4+ T cells do not generally survive for long enough to revert to a resting memory state in vivo.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                6 December 2016
                21 November 2016
                21 November 2016
                : 113
                : 49
                : E7908-E7916
                Affiliations
                [1] aLaboratory of Molecular Immunology, The Rockefeller University , New York, NY 10065;
                [2] bDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104;
                [3] cDepartment of Microbiology, Perelman School of Medicine , University of Pennsylvania, Philadelphia, PA 19104;
                [4] dDepartment of Chemical Engineering, Institute for Medical Engineering & Science, Massachusetts Institute of Technology , Cambridge, MA 02139;
                [5] eDepartment of Physics, Institute for Medical Engineering & Science, Massachusetts Institute of Technology , Cambridge, MA 02139;
                [6] fDepartment of Chemistry, Institute for Medical Engineering & Science, Massachusetts Institute of Technology , Cambridge, MA 02139;
                [7] gDepartment of Biological Engineering, Institute for Medical Engineering & Science, Massachusetts Institute of Technology , Cambridge, MA 02139;
                [8] h Ragon Institute of MGH, MIT, and Harvard , Cambridge, MA 02139;
                [9] iCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA 02215;
                [10] j Howard Hughes Medical Institute, The Rockefeller University , New York, NY 10065
                Author notes
                2To whom correspondence should be addressed. Email: nussen@ 123456rockefeller.edu .

                Contributed by Michel C. Nussenzweig, October 27, 2016 (sent for review October 17, 2016; reviewed by Sharon R. Lewin and Douglas D. Richman)

                Author contributions: J.C.C.L., Y.Z.C., L.B.C., J.A.H., M.C., and M.C.N. designed research; J.C.C.L., Y.Z.C., C.L.L., and A.S. performed research; E.F.K., J.P.B., G.H.L., and A.K.C. contributed new reagents/analytic tools; J.C.C.L., Y.Z.C., E.F.K., J.P.B., G.H.L., T.O., M.J., M.S.S., A.K.C., B.H.H., and M.C.N. analyzed data; and J.C.C.L., Y.Z.C., L.B.C., and M.C.N. wrote the paper.

                Reviewers: S.R.L., University of Melbourne; and D.D.R., University of California, San Diego.

                1J.C.C.L. and Y.Z.C. contributed equally to this work.

                Author information
                http://orcid.org/0000-0003-1467-421X
                http://orcid.org/0000-0003-0434-7733
                Article
                PMC5150408 PMC5150408 5150408 201617789
                10.1073/pnas.1617789113
                5150408
                27872306
                3e1b7e2e-86db-4fe2-bfe6-d3f13befb422

                Freely available online through the PNAS open access option.

                History
                Page count
                Pages: 9
                Funding
                Funded by: HHS | NIH | National Center for Advancing Translational Sciences (NCATS) 100006108
                Award ID: KL2TR001865
                Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 100000060
                Award ID: U01 AI118536
                Categories
                PNAS Plus
                Biological Sciences
                Immunology and Inflammation
                PNAS Plus

                culture,HIV,reservoir,replication-competent,method
                culture, HIV, reservoir, replication-competent, method

                Comments

                Comment on this article